What insulin pen needle size and gauge should be ordered for the Tresiba (insulin degludec) FlexTouch pen?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Needle Specifications for Tresiba FlexTouch Pen

Order 4 mm, 32-gauge pen needles for the Tresiba FlexTouch pen 1.

Recommended Needle Specifications

Length

  • 4 mm pen needles are recommended for all adults and children using Tresiba FlexTouch 1
  • This length is sufficient to traverse the skin and reliably deliver insulin to the subcutaneous tissue while avoiding intramuscular injection
  • If 4 mm needles are unavailable, 5 mm needles are an acceptable backup 1

Gauge (Width)

  • 32-gauge is recommended for most adults with diabetes 1
  • Higher gauge numbers indicate thinner needles, which reduce injection pain
  • The needle wall should be thin to create a larger lumen enabling higher flow rate 1

Additional Needle Features to Consider

  • 5-bevel tip geometry is preferred over 3-bevel to minimize skin penetration force 1
  • Contoured base design distributes pressure more widely across the skin surface compared to posted bases, reducing overall injection force 1
  • Needle lubrication should be present to reduce penetration force 1

FDA-Approved Compatible Needles

According to the Tresiba FDA label, the FlexTouch pen is recommended for use with NovoFine®, NovoFine® Plus, or NovoTwist® disposable needles 2.

Injection Technique Considerations

  • Inject at 90° angle for most adults using 4-5 mm pen needles 1
  • No skin lift is needed for most patients when using 4 mm needles at 90° 1
  • Skin lift IS required for specific populations using 4 mm needles:
    • Low BMI (<19 kg/m²) or lean body mass patients 1
    • Children ≤6 years old 1
    • Older adults with very thin skin (individualized assessment) 1

Critical Safety Points

  • Never reuse needles - this prevents infection, maintains needle sharpness and lubrication, and ensures optimal injection experience 1
  • Never share FlexTouch pens between patients, even if the needle is changed, due to risk of blood-borne pathogen transmission 2
  • Inject insulin at room temperature rather than cold to reduce discomfort 1

Common Pitfalls to Avoid

  • Do not order 6 mm or 8 mm needles - these increase risk of painful intramuscular injection 1
  • Do not use syringes to withdraw insulin from the FlexTouch pen 2
  • Avoid needles with posted bases if patients have dexterity challenges like arthritis, as these concentrate pressure at the injection site 1

Related Questions

For a patient prescribed insulin degludec (Tresiba FlexTouch) 100 U/mL pen to inject 25 units subcutaneously in the morning and 25 units in the evening for a 90‑day supply with no refills, how many pens are needed?
How many 100 units/mL insulin degludec (Tresiba) pens are needed for a patient who takes 80 units twice daily?
A patient on insulin glargine (Lantus) 20 U daily and prednisone 15 mg in the morning and 10 mg in the evening with a carbohydrate‑to‑insulin ratio of 1 U per 10 g carbs will have the evening prednisone reduced to 5 mg; how should the basal insulin dose and carbohydrate‑to‑insulin ratio be adjusted?
What is the typical nighttime glucose profile from bedtime to early morning for an adult with type 2 diabetes mellitus and an HbA1c of 8% who is taking metformin 1000 mg twice daily and bedtime basal insulin glargine 20 units?
What is the appropriate discharge regimen for a patient receiving a high daily dose of intravenous insulin, transitioning to pre‑meal rapid‑acting insulin boluses, basal insulin glargine, and oral hypoglycemic agents?
Can you help me study for my exam covering common gynecologic conditions, breast health and gynecologic cancers (including genetic mutations and surveillance), and menopause (hormone therapy, genitourinary syndrome of menopause, and osteoporosis) with focus on signs, symptoms, clinical findings, diagnostic tests, and treatments?
What is the recommended titration protocol for dexmedetomidine (Precedex) in adult patients, including loading dose, infusion rates, and monitoring parameters?
What is the recommended management approach for Parkinson disease?
Is metronidazole safe to use during pregnancy, and what is the recommended dosing regimen?
Is frequent low‑glucose readings serious in a non‑diabetic woman 11 years after sleeve gastrectomy?
How do I prepare a bedside hypotonic saline solution for hypernatremia, when should I use free water versus 5% dextrose in water, and what volume should be administered to correct the sodium excess?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.